Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Pain 7 Neoplasms 3 Pain, Postoperative 2 Malignant Female Reproductive System Neoplasm 2 Hematologic Neoplasms 2 Emergencies 2 Agnosia 2 Uterine Cervical Neoplasms 1 Tumor Surgery 1 Sarcoma 1 Rectal Neoplasms 1 Pulmonary Nodule 1 Prostatic Neoplasms 1 Postoperative Complications 1 Pancreatic Neoplasms 1 Pain, Intractable 1 Ovarian Neoplasms 1 Neuralgia 1 Neoplasm Metastasis 1 Mucositis 1 Lymphoma, Follicular 1 Liver Neoplasms 1 Leukemia 1 Kidney Neoplasms 1 Intraoperative Complications 1 Ileus 1 Fallopian Tube Neoplasms 1 Endometrial Neoplasms 1 Duodenal Neoplasms 1 Diverticulosis, Colonic 1

Interventions

Pregabalin 5 Lidocaine 4 Surveys and Questionnaires 3 Bupivacaine 3 ziconotide 2 Transcranial Magnetic Stimulation 2 Oxycodone 2 Gabapentin 2 Capsaicin 2 Amitriptyline 2 onabotulinum toxin A 1 Yoga 1 Vitamin B 6 1 Vitamin B 12 1 Vinorelbine 1 Vincristine 1 Transcutaneous Electric Nerve Stimulation 1 Thalidomide 1 Telmisartan 1 Tapentadol 1 Spinal Cord Stimulation 1 Sodium Chloride 1 Saline Solution 1 Radiofrequency Ablation 1 Plastic Surgery Procedures 1 Paclitaxel 1 Oxaliplatin 1 Morphine 1 Methadone 1 Manipulation, Osteopathic 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Neuralgia × Hydromorphone × Clear all

NCT01946555 2016-04-14

RER

Mario Negri Institute for Pharmacological Research

Cancer Pain, Neoplasms, Neuralgia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡